CG
SRNE

Cutler Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Cutler Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-700
Closed -$1K – 5980
2022
Q1 		$1K Buy
+700
New +$2.18K ﹤0.01% 5178
2021
Q1 		– Sell
-2,000
Closed -$3K – 6539
2020
Q4 		$3K Sell
2,000
-27,900
-93% -$224K ﹤0.01% 4062
2020
Q3 		$39K Buy
29,900
+20,800
+229% +$190K ﹤0.01% 1973
2020
Q2 		$20K Buy
+9,100
New +$34.8K ﹤0.01% 2399
2017
Q2 		– Sell
-1,000
Closed -$1K – 7324
2017
Q1 		$1K Buy
+1,000
New +$5.01K ﹤0.01% 6087
2016
Q3 		– Sell
-1,800
Closed -$1K – 7586
2016
Q2 		$1K Buy
+1,800
New +$11.5K ﹤0.01% 6364

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Cutler Group's SRNE Position: Q1 2023 in Review

Cutler Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 1,100 shares.

Cutler Group first reported a position in SRNE in Q4 2015 and held it in 21 quarters. The position peaked at $50K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Cutler Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 1,100 Sorrento Therapeutics, Inc. shares in Q1 2023.
  • Cutler Group first reported a position in Sorrento Therapeutics, Inc. in Q4 2015 and held it in 21 quarters.
  • Cutler Group's Sorrento Therapeutics, Inc. position peaked at $50K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.